Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2007 1
2011 3
2012 3
2013 8
2014 7
2015 5
2016 4
2017 6
2018 1
2019 1
2020 3
2021 4
2022 6
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.
Ciccone G, De Luca S, Oderda M, Munoz F, Krengli M, Allis S, Baima CG, Barale M, Bartoncini S, Beldì D, Bellei L, Bellissimo AR, Bernardi D, Biamino G, Billia M, Borsa R, Cante D, Castelli E, Cattaneo G, Centrella D, Collura D, Coppola P, Dalmasso E, Di Stasio A, Fasolis G, Fiorio M, Garibaldi E, Girelli G, Griffa D, Guercio S, Migliari R, Molinaro L, Montefiore F, Montefusco G, Moroni M, Muto G, Ponti di Sant'Angelo F, Ruggiero L, Ruo Redda MG, Serao A, Squeo MS, Stancati S, Surleti D, Varvello F, Volpe A, Zaramella S, Zarrelli G, Zitella A, Bollito E, Gontero P, Porpiglia F, Galassi C, Bertetto O; START Collaborative Group. Ciccone G, et al. Among authors: cante d. JAMA Netw Open. 2023 Oct 2;6(10):e2338039. doi: 10.1001/jamanetworkopen.2023.38039. JAMA Netw Open. 2023. PMID: 37847502 Free PMC article.
Is the combination of Cetuximab with chemo-radiotherapy regimens worthwhile in the treatment of locally advanced head and neck cancer? A review of current evidence.
Numico G, Franco P, Cristofano A, Migliaccio F, Spinazzé S, Silvestris N, Cante D, Sciacero P, La Porta MR, Girelli F, Ricardi U. Numico G, et al. Among authors: cante d. Crit Rev Oncol Hematol. 2013 Feb;85(2):112-20. doi: 10.1016/j.critrevonc.2012.05.005. Epub 2012 Jun 27. Crit Rev Oncol Hematol. 2013. PMID: 22743346 Review.
Leptomeningeal metastasis from prostate cancer.
Cante D, Franco P, Sciacero P, Girelli G, Casanova Borca V, Pasquino M, Migliaccio F, Tofani S, Grassi L, Marra A, Ozzello F, La Porta MR, Ricardi U. Cante D, et al. Tumori. 2013 Jan-Feb;99(1):6e-10e. doi: 10.1177/030089161309900124. Tumori. 2013. PMID: 23549020
The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study.
Leonardi MC, Pepa M, Luraschi R, Vigorito S, Dicuonzo S, Isaksson LJ, La Porta MR, Marino L, Ippolito E, Huscher A, Argenone A, De Rose F, Cucciarelli F, De Santis MC, Rossi F, Prisco A, Guarnaccia R, Tabarelli de Fatis P, Palumbo I, Colangione SP, Mormile M, Ravo V, Fozza A, Aristei C, Orecchia R, Cattani F, Jereczek-Fossa BA; Collaborative Italian Association of Radiotherapy and Clinical Oncology (AIRO) Breast Study Group. Leonardi MC, et al. Radiother Oncol. 2022 Mar;168:113-120. doi: 10.1016/j.radonc.2022.01.004. Epub 2022 Jan 13. Radiother Oncol. 2022. PMID: 35033602
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation.
Cozzarini C, Olivieri M, Magli A, Cante D, Noris Chiorda B, Munoz F, Faiella A, Olivetta E, Deantoni C, Fodor A, Signor MA, Petrucci E, Avuzzi B, Ferella L, Pastorino A, Garibaldi E, Gatti M, Rago L, Statuto T, Rancati T, Briganti A, Montorsi F, Valdagni R, Sanguineti G, Di Muzio NG, Fiorino C. Cozzarini C, et al. Among authors: cante d. Radiother Oncol. 2022 Oct;175:26-32. doi: 10.1016/j.radonc.2022.08.001. Epub 2022 Aug 4. Radiother Oncol. 2022. PMID: 35934169
55 results